Results for tag: "Gleevec"

Gleevec is a drug used to treat certain types of leukemia, a type of cancer of the blood and bone marrow. It is a targeted therapy, meaning it works by targeting specific molecules involved in the growth and spread of cancer cells. Gleevec is a tyrosine kinase inhibitor, meaning it blocks the activity of certain enzymes that are involved in the growth and spread of cancer cells. It is used to treat chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). Gleevec is a widely used drug in the treatment of leukemia, and is considered to be one of the most successful targeted therapies for cancer. It has been shown to be effective in treating CML and Ph+ ALL, and has been used in combination with other drugs to treat other types of leukemia. Some companies in the Gleevec market include Novartis, Pfizer, and Bristol-Myers Squibb. Show Less Read more